Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C16H22N4O2 |
| Molecular Weight | 302.3715 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(N(C)C)C(=O)NC1=C(C)N(C)N(C1=O)C2=CC=CC=C2
InChI
InChIKey=UQNCVOXEVRELFR-UHFFFAOYSA-N
InChI=1S/C16H22N4O2/c1-11-14(17-15(21)12(2)18(3)4)16(22)20(19(11)5)13-9-7-6-8-10-13/h6-10,12H,1-5H3,(H,17,21)
| Molecular Formula | C16H22N4O2 |
| Molecular Weight | 302.3715 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effect of temperature on intestinal transfer and tissue uptake of sulfanilamide and aminopropyron in vitro. | 1986-01 |
|
| Further production and characterization of antibodies reactive with pyrazolone derivatives. | 1980 |
|
| Influence of some anti-inflammatory, antipyretic and analgesic agents on urinary enzyme level in rats. | 1978-02 |
|
| [Combined use of bucolome and pyrazolone derivatives (1). Pharmacological activities and blood concentration]. | 1975-09 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:43:21 GMT 2025
by
admin
on
Mon Mar 31 18:43:21 GMT 2025
|
| Record UNII |
JB5F72V65T
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3670
Created by
admin on Mon Mar 31 18:43:21 GMT 2025 , Edited by admin on Mon Mar 31 18:43:21 GMT 2025
|
PRIMARY | |||
|
222-999-4
Created by
admin on Mon Mar 31 18:43:21 GMT 2025 , Edited by admin on Mon Mar 31 18:43:21 GMT 2025
|
PRIMARY | |||
|
JB5F72V65T
Created by
admin on Mon Mar 31 18:43:21 GMT 2025 , Edited by admin on Mon Mar 31 18:43:21 GMT 2025
|
PRIMARY | |||
|
107150
Created by
admin on Mon Mar 31 18:43:21 GMT 2025 , Edited by admin on Mon Mar 31 18:43:21 GMT 2025
|
PRIMARY | |||
|
m33
Created by
admin on Mon Mar 31 18:43:21 GMT 2025 , Edited by admin on Mon Mar 31 18:43:21 GMT 2025
|
PRIMARY | Merck Index | ||
|
62951-82-0
Created by
admin on Mon Mar 31 18:43:21 GMT 2025 , Edited by admin on Mon Mar 31 18:43:21 GMT 2025
|
SUPERSEDED | |||
|
100000077689
Created by
admin on Mon Mar 31 18:43:21 GMT 2025 , Edited by admin on Mon Mar 31 18:43:21 GMT 2025
|
PRIMARY | |||
|
3690-04-8
Created by
admin on Mon Mar 31 18:43:21 GMT 2025 , Edited by admin on Mon Mar 31 18:43:21 GMT 2025
|
PRIMARY | |||
|
SUB12856MIG
Created by
admin on Mon Mar 31 18:43:21 GMT 2025 , Edited by admin on Mon Mar 31 18:43:21 GMT 2025
|
PRIMARY | |||
|
DTXSID20874826
Created by
admin on Mon Mar 31 18:43:21 GMT 2025 , Edited by admin on Mon Mar 31 18:43:21 GMT 2025
|
PRIMARY |